UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity

British journal of pharmacology, 2016-08, Vol.173 (15), p.2390-2401

2016

Volltextzugriff (PDF)

C70 THE NEXT NEW THERAPEUTIC TARGET? TRANSLATIONAL STUDIES OF COPD THERAPIES: Inhibition Of Neutrophil Serine Protease Activation With The Reversible Dpp1 Inhibitor Azd7986

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings

Naunyn-Schmiedeberg's archives of pharmacology, 2001-04, Vol.363 (4), p.448-455

2001

Volltextzugriff (PDF)

Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges

Psychopharmacologia, 1999-04, Vol.143 (4), p.408-416

1999

Volltextzugriff (PDF)

Open‐Field Behavioural Alterations in Liver‐Impaired and Sham‐Operated Rats after Acute Exposure to the Antidepressant Venlafaxine

Basic & clinical pharmacology & toxicology, 2005-09, Vol.97 (3), p.155-161

2005

Volltextzugriff (PDF)

Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy

European neuropsychopharmacology, 2002-08, Vol.12 (4), p.327-336

2002

Volltextzugriff (PDF)

Quantitative studies of testicular atrophy following portacaval shunt in rats

Hepatology (Baltimore, Md.), 1998-12, Vol.28 (6), p.1461-1466

1998

Volltextzugriff (PDF)

Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy

Clinical neuropharmacology, 1998-09, Vol.21 (5), p.296-306

1998

Volltextzugriff (PDF)

Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment

Chirality (New York, N.Y.), 2002, Vol.14 (4), p.347-350

2002

Volltextzugriff (PDF)

Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy

Clinical neuropharmacology, 2001-11, Vol.24 (6), p.324-333

2001

Volltextzugriff (PDF)

Citalopram and release of brain 5-HT in experimental chronic hepatic encephalopathy

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.236S-236S

1997

Volltextzugriff (PDF)

P-chloroamphetamine- and D-fenfluramine-induced brain 5-HT release in chronic hepatic encephalopathy

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.160S-160S

1997

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats

Clinical neuropharmacology, 1999-11, Vol.22 (6), p.327-336

1999

Volltextzugriff (PDF)

Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy

Clinical neuropharmacology, 2000-11, Vol.23 (6), p.304-317

2000

Volltextzugriff (PDF)

Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy : Implications for thymoleptic drug safety in liver insufficiency

Clinical neuropharmacology, 1997-12, Vol.20 (6), p.511-522

1997

Volltextzugriff (PDF)

P.1.016 Effects of a single venlafaxine challenge on the neocortical monoamine output in experimental chronic hepatic encephalopathy

European neuropsychopharmacology, 1997-09, Vol.7, p.S139-S139

1997

Volltextzugriff (PDF)

P.1.173 In vivo studies on the brain serotonin output in experimental chronic hepatic encephalopathy

European neuropsychopharmacology, 1997-09, Vol.7, p.S190-S190

1997

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic responses to chronic admininstration of the selective serotonin reuptake inhibitor citalopram in rats

Clinical neuropharmacology, 2000, Vol.22, p.327

2000

Volltextzugriff (PDF)

p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy

Metabolic brain disease, 1997-09, Vol.12 (3), p.229-235

1997

Volltextzugriff (PDF)

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study

BMC public health, 2019-02, Vol.19 (1), p.151-151, Article 151

2019

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Male
(14)
Science & Technology
(14)
Animals
(13)
Rats
(13)
Rats, Sprague-Dawley
(13)
Pharmacology & Pharmacy
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Medicin
(8)
Medicine
(8)
Neurosciences & Neurology
(8)
Pharmacology. Drug Treatments
(7)
Venlafaxine Hydrochloride
(7)
Clinical Neurology
(6)
Hepatic Encephalopathy - Drug Therapy
(6)
Hepatic Encephalopathy - Metabolism
(6)
Microdialysis
(6)
Serotonin - Metabolism
(6)
Behavior, Animal - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity

C70 THE NEXT NEW THERAPEUTIC TARGET? TRANSLATIONAL STUDIES OF COPD THERAPIES: Inhibition Of Neutrophil Serine Protease Activation With The Reversible Dpp1 Inhibitor Azd7986

Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings

Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges

Open‐Field Behavioural Alterations in Liver‐Impaired and Sham‐Operated Rats after Acute Exposure to the Antidepressant Venlafaxine

Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy

Quantitative studies of testicular atrophy following portacaval shunt in rats

Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy

Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment

Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy

Citalopram and release of brain 5-HT in experimental chronic hepatic encephalopathy

P-chloroamphetamine- and D-fenfluramine-induced brain 5-HT release in chronic hepatic encephalopathy

Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats

Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy

Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy : Implications for thymoleptic drug safety in liver insufficiency

P.1.016 Effects of a single venlafaxine challenge on the neocortical monoamine output in experimental chronic hepatic encephalopathy

P.1.173 In vivo studies on the brain serotonin output in experimental chronic hepatic encephalopathy

Pharmacokinetic and pharmacodynamic responses to chronic admininstration of the selective serotonin reuptake inhibitor citalopram in rats

p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study

Suchergebnisse filtern